Novartis Acquires Arctos Medical, Expanding its Optogenetics Portfolio
Novartis AG acquired Arctos Medical AG for an undisclosed amount, adding a preclinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its ophthalmology portfolio.
- Gene Therapy, Cell Therapy
- Acquisition of Private Biotech
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com